with periodic movements in sleep, was found to be more fragmented than in hypersomniacs with the same condition. 5 6 We have recently demonstrated in an open study the beneficial effect of clonazepam in the treatment of periodic movements in sleep.7 In order to confirm these results and to determine the range of effective dosages, we performed a double-blind study with clonazepam.
Patients and methods
Twenty consecutive periodic movements in sleep patients, 12 men (age range, 30-63 years) and eight women (age range, 45-70 years) participated. Eleven complained of excessive daytime sleepiness (EDS group) and nine complained of poor nocturnal sleep (insomnia group). In the insomnia group, three patients also suffered from restless legs syndrome (RLS A point of interest is the finding that effective treatment does not require a complete suppression of all leg movements. For the entire drug group the total number of leg movements was reduced to about half, and the number of leg movements associated with arousals to about one third. This may indicate that the significant factor in determining the degree of sleep disruption is the number of leg movements associated with arousal, rather than the total number of movements per se.
